Link Cell Therapies, a South San Francisco, California-based oncology cell therapy company utilizing its proprietary logic-gating technology to develop next-generation CAR-T therapeutics for solid tumors and hematologic malignancies, raised $30m in an expansion of its Series A financing. Link’s previously announced $60m Series A financing led by Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc., with participation from founding inves...See more